Form D · Other Health Care
MYDNA, INC
Houston, TX · CIK 0001839591
Offering snapshot reported Jan 11, 2021 · SEC filing
- Reported sold
- $72.1M Offering amount: $72.1M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2021 | Initial | $72,100,000 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $960K
- Finders' fees
- $0
- Form D file number
- 021-385814
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ERIC BROWN | 1925478 | STILLPOINT CAPITAL LLC · CRD 133146 |
| PAUL ENDERLE | 6230369 | STILLPOINT CAPITAL LLC · CRD 133146 |
Source: Form D, filed Jan 11, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lior Rauchberger | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1445 North Loop W Ste 820
Houston, TX, 77008
Houston, TX, 77008